Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 136   

Articles published

VRX 257.53 +3.25 (1.28%)
price chart
Valeant Pharmaceuticals International Inc topples RBC to emerge as Canada's ...
MONTREAL - Valeant Pharmaceuticals International Inc. has surpassed Royal Bank of Canada as the country's largest company by market value after shares shot up in the wake of solid second quarter results.
Buy Valeant Pharmaceuticals Intl Inc. Now, or You'll Regret it Later  The Motley Fool Canada (blog)
Valeant profit beats estimates as US sales stay strong  Yahoo News
Valeant Pharmaceuticals International Inc. is now worth more than Toronto ...
Valeant is in talks to acquire Amoun Pharmaceutical Co., one of the largest drugmakers in Egypt, according to people with knowledge of the matter, Bloomberg reported May 20.
Valeant now worth more than TD Bank as drugmakers surge  bnn.ca
Valeant challenges TD Bank to become Canada's second-largest stock  The Globe and Mail
Valeant Pharmaceuticals International Inc expands in Middle East with $800 ...
Valeant Pharmaceuticals International, Inc. said it will buy a major Egyptian pharmaceutical company for about US$800 million as a platform for further expansion in the Middle East and North Africa.
Valeant Pharmaceuticals Agrees To Acquire Amoun Pharmaceutical  Canada NewsWire (press release)
Buzz Stocks: Honeywell International Inc., Hertz Global Holdings Inc, and ...  Schaeffers Research (blog)
2 Reasons to Buy Valeant Pharmaceuticals Intl. Inc.
When building a portfolio, investors try to balance adding stocks that pay dividends with stocks that are focused on growth. Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is clearly a candidate for the latter type of stock. Valeant is one of ...
Large Inflow of Money Witnessed in Valeant Pharmaceuticals International, Inc.  Insider Trading Report
Earnings Surprise in Focus - Valeant Pharmaceuticals International, Inc ...  Investor Newswire
Valeant Pharmaceuticals International Inc in advanced talks to buy Amoun ...
Valeant Pharmaceuticals International Inc. is in advanced negotiations to acquire Egyptian drugmaker Amoun Pharmaceutical Co.
Could the CEO of Valeant Pharmaceuticals Intl Inc. Be the Next Warren Buffett?  The Motley Fool Canada (blog)
Valeant Pharmaceuticals International, Inc. (VRX) Files Form 4 Insider ...  Insider Trading Report
Valeant Pharmaceuticals International Inc's biggest deal yet seen as a bet on ...
Canadian PressChief Executive Officer Mike Pearson said Valeant Pharmaceuticals International Inc is still focused on small- to medium-sized acquisitions, and may consider a larger deal if one presents itself.
Valeant To Acquire Salix Pharmaceuticals For $158.00 Per Share In Cash  Canada NewsWire (press release)
Why Aetna Inc (AET), Valeant Pharmaceuticals Intl Inc (VRX) and Tower ...  Investorplace.com
Valeant Pharmaceuticals International Inc CEO primed for more deals
Michael Pearson's penchant for acquisitions has helped catapult Valeant Pharmaceuticals International Inc. to the heavyweight ranks of the TSX Composite Index, and the company's chief executive officer shows no signs of slowing down the deal flow.
Billionaire John Paulson Doubles Down on Valeant Pharmaceuticals Intl Inc.  The Motley Fool Canada
Valeant CEO expects major boost in Asia revenue by 2020  The Globe and Mail (subscription)
Valeant Pharmaceuticals International Inc. is becoming the 800-pound gorilla ...
Scott Eells/Bloomberg Valeant Pharmaceuticals International Inc. chief executive Michael Pearson, has stated his company's goal is to become one of the top five largest drugmakers in the world by 2016, which means reaching a market value of at least ...
At midday: TSX sags on global jitters  The Globe and Mail
North American markets close lower for a second straight day; loonie up  Edmonton Journal
Valeant Pharmaceuticals International Inc's bid for Salix Pharmaceuticals ...
Canadian Press//Ryan RemiorzValeant Pharmaceuticals International Inc's chief executive Mike Pearson agreed to buy bowel drug maker Salix Pharmaceuticals Ltd in late February for about US$10 billion, or US$158 all cash offer per share.
Valeant Comments On Endo Offer To Acquire Salix  PR Newswire (press release)
Valeant Pharmaceuticals Intl Inc Drops As Endo International Makes An Offer ...  Bidness ETC
Valeant Pharmaceuticals International Inc wooing Egyptian drugmaker, wants to ...
Valeant Pharmaceuticals International Inc. is in talks to acquire one of the largest drugmakers in Egypt to expand in both veterinary and human medicines, according to people with knowledge of the matter.
Valeant said to be in talks to acquire Egyptian drug maker Amoun  The Globe and Mail (subscription)
Valeant in talks to buy Egyptian drugmaker Amoun Pharma: Bloomberg  Reuters UK